Delivery Order SPE2DB24D3015-SPE2DB25FFYDE

Award Date 2/20/25
Potential Completion Date 2/21/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,150,437 tablets of the medication Viberzi (75 mg). The firm-fixed-price delivery order has a ceiling value of $2,174.62 and an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Viberzi 100 mg tablets to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The $3,793.54 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of May 2, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Viberzi 100mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,686.83, is a Firm Fixed Price Delivery Order with a completion date of July 11, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,576.69 firm fixed-price delivery order is for the medication Viberzi 100 mg Tablet 60s, with a performance period ending on May 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $2,773.34 and has a firm fixed price pricing type. The contract is for the supply of the medication Viberzi 75 mg Tablet in 60-count packages, with a period of performance through January 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,100.38, is for the delivery of Viberzi 75 mg tablet 60s to the Defense Logistics Agency (DLA). The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.42 firm-fixed-price delivery order is for the pharmaceutical product VIBERZI 75 MG TABLET 60S. The contract has an ultimate completion date of June 25, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.81, is for the delivery of 60 tablets of the medication Viberzi 75 mg. The contract has an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,707.63 firm fixed price contract is for the delivery of Viberzi 100 mg Tablets in quantities of 60. The contract has a performance period ending on May 29, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which allows the company to...
This federal contract award, valued at $3,472.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract to supply 4,568,038,385 units of the pharmaceutical product Viberzi 75 mg tablets. The contract has an ultimate completion date of April 28, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract, indicating open...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFYDE
    Delivery Order

This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Viberzi 100 mg tablets for the Defense Logistics Agency (DLA). The $2,222.21 firm fixed-price delivery order has a completion date of February 21, 2025. The contract is not designated as a set-aside.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/22/25, 8:13 PM